BENJAMIN M. LIMSON, M.D.; MONROE J. ROMANSKY, M.D., F.A.C.P.; JAMES G. SHEA, M.D.
The typical pulmonary lesion produced by Friedländer's bacillus, or Klebsiella pneumoniae, is a fulminating lobar pneumonia particularly noted for its high mortality rate. Although the prognosis has been altered appreciably since the use of streptomycin1 or, more recently, chlortetracycline, oxytetracycline or chloramphenicol,2 the disease continues to present many difficulties in management. Attention has also been focused on the more benign and chronic forms of respiratory infection with Friedländer's bacillus.3, 4 The pulmonary diseases caused by this microörganism have been classified as follows: (1) acute primary Friedländer's pneumonias; (2) acute mixed infections or secondary infections, and (3) chronic respiratory infections.5 In
LIMSON BM, ROMANSKY MJ, SHEA JG. AN EVALUATION OF TWENTY-TWO PATIENTS WITH ACUTE AND CHRONIC PULMONARY INFECTION WITH FRIEDLÄNDER'S BACILLUS1. Ann Intern Med. ;44:1070–1081. doi: 10.7326/0003-4819-44-6-1070
Download citation file:
Published: Ann Intern Med. 1956;44(6):1070-1081.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use